Richardson PG, Durie BG, Rosiñol L, Mateos M-V, Dispenzieri A, Moreau P, Kumar S, Raje N, Munshi N, Laubach JP, O’Gorman P, O’Donnell E, Voorhees P, Facon T, Bladé J, Lonial S, Perrot A, Anderson KC. Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma. haematol [Internet]. 2023Nov.1 [cited 2024Nov.27];108(11):2894-912. Available from: https://haematologica.org/article/view/haematol.2022.282624